Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients

Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients

<span style="color: windowtext;">Hemophilia A is a rare congenital bleeding disorder caused by a deficiency of functionally active coagulation factor VIII (FVIII). Most patients with the severe form of the disease require FVIII replacement therapies, which are often associated with t...

Full description

Bibliographic Details
Main Authors: Birgit M. Reipert, Christoph J. Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L. Brown
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Clinical Medicine
Subjects:
hemophilia A
multi-center clinical research study
gene expression signatures in human PBMC
quality assurance program
qualification of operators in Hemophilia treatment centers
Online Access:https://www.mdpi.com/2077-0383/12/5/2080

Internet

https://www.mdpi.com/2077-0383/12/5/2080

Similar Items